Alternative sources of pluripotent stem cells: Scientific solutions to an ethical dilemma

Stem Cells and Development

Volumn 17, Issue 1, 2008, Pages 1-10

  Rao, Mahendra ^a,b   Condic, Maureen L ^c  

^a INVITROGEN CORPORATION   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLASTOMERE; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; FERTILIZATION IN VITRO; GERM CELL; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; PARTHENOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

CELL CULTURE TECHNIQUES; EMBRYONIC STEM CELLS; ETHICS, RESEARCH; GERM CELLS; HUMANS; PARTHENOGENESIS; PLURIPOTENT STEM CELLS; UNITED STATES;

EID: 39449104790     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0013     Document Type: Article

References (71)

1. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
2. Rao MS. (2006). Mired in the quagmire of uncertainty: the "catch-22" of embryonic stem cell research. Stem Cells Dev 15:492-496.
3. Rao MS. (2006). Embryonic stem cell research and U.S. policy. Stem Cells 24:1412-1413.
4. Rao MS. (2006). Are there morally acceptable alternatives to blastocyst derived ESC? J Cell Biochem 98:1054-1061.
5. Magnus T, Y Liu, GC Parker and MS Rao. (2008). Stem cell myths. Philos Trans R Soc Lond B Biol Sci 363:9-22.
6. Byrne JA, DA Pedersen, LL Clepper, M Nelson, WG Sanger, S Gokhale, DP Wolf and SM Mitalipov. (2007). Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450:497-502.
7. French A, C Adams, L Anderson, J Kitchen, M Hughes and S Wood. (2008). Development of human cloned blastocysts following somatic cell nuclear transfer (SCNT) with adult fibroblasts. Stem Cells, Epub ahead of print, DOI:10.1634/stemcells.2007-0252
8. Pralong D, AO Trounson and PJ Verma. (2006). Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome. Stem Cell Rev 2:331-340.
9. Verlinsky Y, N Strelchenko, A Shkumatov, V Kukharenko, O Verlinsky and A Kuliev. (2006). Cytoplasmic cell fusion: Stembrid technology for reprogramming pluripotentiality. Stem Cell Rev 2:297-299.
10. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
11. Maherali N, R Sridaran, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, R Yachenchko, J Tchieu, R Jaenisch, K Plath and K Hochedinger. (2007). Directly Reprogrammed Fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70.
12. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
13. Wernig M, A Meissner, R Foreman, T Brambrink, M Ku, K Hochedlinger, BE Bernstein and R Jaenisch. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324.
14. Park IH, R Zhao, JA West, A Yabuuchi, H Huo, TA Ince, PH Lerou, MW Lensch and GQ Daley. (2007). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.
15. Takahashi K, K Okita, M Nakagawa and S Yamanaka. (2007). Induction of pluripotent stem cells from fibroblast cultures. Nature Protoc 2:3081-3089.
16. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, Slukvin, II and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
17. Hanna J, M Wernig, S Markoulaki, CW Sun, A Meissner, JP Cassady, C Beard, T Brambrink, LC Wu, TM Townes and R Jaenisch. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923.
18. Nakagawa M, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, K Okita, Y Mochiduki, N Takizawa and S Yamanaka. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnol 26:101-106.
19. Meissner A and R Jaenisch. (2006). Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 439:212-215.
20. Byrnes WM. (2007). The flawed scientific basis of the altered nuclear transfer-oocyte assisted reprogramming (ANT-OAR) proposal. Stem Cell Rev 3:60-65.
21. Condic M. (2008). Alternative sources of pluripotent stem cells: altered nuclear transfer. Cell Proliferation 41 (Suppl 1):7-19.
22. Condic ML and SB Condic. (2005). Defining organisms by organization. Natl Cathol Bioeth Q 5:331-353.
23. Hoehner PJ. (2005). "Altered nuclear transfer": probing the nature of being human. Natl Cathol Bioeth Q 5:261-269.
24. Arkes H, NP Austriaco, T Berg, EC Brugger, NM Cameron, J Capizzi, ML Condic, SB Condic, KT FitzGerald, K Flannery, EJ Furton, RP George, T George, A Gomez-Lobo, G Grisez, M Grompe, JM Haas, R Hamerton-Kelly, JC Harvey, PJ Hoehner, WB Hurlbut, JF Kilner, P Lee, WE May, G Miranda, CB Mitchell, JJ Myers, C Oleson, T Pacholczyk, PF Ryan, WL Saunders, D Stevens, SW Swetland, ME Whelan and T Williams. (2005). Production of pluripotent stem cells by oocyte-assisted reprogramming: joint statement with signatories. Natl Cathol Bioeth Q 5:579-583.
25. Guan K, K Nayernia, LS Maier, S Wagner, R Dressel, JH Lee, J Nolte, F Wolf, M Li, W Engel and G Hasenfuss. (2006). Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440:1199-1203.
26. Kanatsu-Shinohara M, M Ikawa, M Takehashi, N Ogonuki, H Miki, K Inoue, Y Kazuki, J Lee, S Toyokuni, M Oshimura, A Ogura and T Shinohara. (2006). Production of knockout mice by random or targeted mutagenesis in spermatogonial stem cells. Proc Natl Acad Sci USA 103:8018-8023.
27. de Rooij DG. (2006). Rapid expansion of the spermatogonial stem cell tool box. Proc Natl Acad Sci USA 103:7939-7940.
28. Kanatsu-Shinohara M and T Shinohara. (2006). The germ of pluripotency. Nature Biotechnol 24:663-664.
29. Pan Y, X Chen, S Wang, S Yang, X Bai, X Chi, K Li, B Liu and L Li. (2005). In vitro neuronal differentiation of cultured human embryonic germ cells. Biochem Biophys Res Commun 327:548-556.
30. Coullin P. (2005). From human andro- and parthenogenesis (hydatidiform moles and benign ovarian teratomas) to cancer. Gynecol Obstet Fertil 33:469-482.
31. de Grouchy J. (1980). Human parthenogenesis: a fascinating single event. Biomedicine 32:51-53.
32. Kaufman MH, EJ Robertson, AH Handyside and MJ Evans. (1983). Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol 73:249-261.
33. Kaufman MH, MJ Evans, EJ Robertson and A Bradley. (1984). Influence of injected pluripotential (EK) cells on haploid and diploid parthenogenetic development. J Embryol Exp Morphol 80:75-86.
34. Szabo P and JR Mann. (1994). Expression and methylation of imprinted genes during in vitro differentiation of mouse parthenogenetic and androgenetic embryonic stem cell lines. Development 120:1651-1660.
35. Cibelli JB, KA Grant, KB Chapman, K Cunniff, T Worst, HL Green, SJ Walker, PH Gutin, L Vilner, V Tabar, T Dominko, J Kane, PJ Wettstein, RP Lanza, L Studer, KE Vrana and MD West. (2002). Parthenogenetic stem cells in nonhuman primates. Science 295:819.
36. Suemori H, T Tada, R Torii, Y Hosoi, K Kobayashi, H Imahie, Y Kondo, A Iritani and N Nakatsuji. (2001). Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI. Dev Dyn 222:273-279.
37. Vrana KE, JD Hipp, AM Goss, BA McCool, DR Riddle, SJ Walker, PJ Wettstein, LP Studer, V Tabar, K Cunniff, K Chapman, L Vilner, MD West, KA Grant and JB Cibelli. (2003). Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci USA 100 (Suppl 1):11911-11916.
38. Spindle A, KS Sturm, M Flannery, JJ Meneses, K Wu and RA Pedersen. (1996). Defective chorioallantoic fusion in mid-gestation lethality of parthenogenone ↔ tetraploid chimeras. Dev Biol 173:447-458.
39. Kawasaki H, H Suemori, K Mizuseki, K Watanabe, F Urano, H Ichinose, M Haruta, M Takahashi, K Yoshikawa, S Nishikawa, N Nakatsuji and Y Sasai. (2002). Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci USA 99:1580-1585.
40. Lin G, Q OuYang, X Zhou, Y Gu, D Yuan, W Li, G Liu, T Liu and G Lu. (2007). A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res 17:999-1007.
41. Mai Q, Y Yu, T Li, L Wang, MJ Chen, SZ Huang, C Zhou and Q Zhou. (2007). Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res 17:1008-1019.
42. Revazova ES, NA Turovets, OD Kochetkova, LS Agapova, JL Sebastian, MV Pryzhkova, VI Smolnikova, LN Kuzmichev and JD Janus. (2007). HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells DOI:10.1089/clo.2007.0063
43. Revazova ES, NA Turovets, OD Kochetkova, LB Kindarova, LN Kuzmichev, JD Janus and MV Pryzhkova. (2007). Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 9:432-449.
44. Austriaco NP. (2002). On static eggs and dynamic embryos: a systems perspective. Natl Cathol Bioeth Q 2:659-683.
45. Elliott KC. (2005). Developmental systems theory and human embryos: a response to Austriaco. Natl Cathol Bioeth Q 5:249-259.
46. Huarte J and A Suarez. (2004). On the status of parthenotes: defining the developmental potentiality of a human embryo. Natl Cathol Bioeth Q 4:755-770.
47. Jones NL and WP Cheshire. (2005). Can artificial techniques supply morally neutral human embryos for research? Part I. Creating novel categories of human embryos. Ethics Med 21:29-40.
48. Latkovic MS. (2002). The science and ethics of parthenogenesis. Natl Cathol Bioeth Q 2:245-255.
49. Charlesworth B. (2006). The evolutionary biology of sex. Curr Biol 16:R693-R695.
50. Normark BB. (2006). Perspective: maternal kin groups and the origins of asymmetric genetic systems-genomic imprinting, haplodiploidy, and parthenogenesis. Evolution Int J Org Evolution 60:631-642.
51. Robertson EJ, MJ Evans and MH Kaufman. (1983). X-chromosome instability in pluripotential stem cell lines derived from parthenogenetic embryos. J Embryol Exp Morphol 74:297-309.
52. Tarkowski AK. (1971). Recent studies on parthenogenesis in the mouse. J Reprod Fertil Suppl 14:31-39.
53. Abbott TM, WJ Hermann, Jr. and RE Scully. (1984). Ovarian fetiform teratoma (homunculus) in a 9-year-old girl. Int J Gynecol Pathol 2:392-402.
54. Kuno N, K Kadomatsu, M Nakamura, T Miwa-Fukuchi, N Hirabayashi and T Ishizuka. (2004). Mature ovarian cystic teratoma with a highly differentiated homunculus: a case report. Birth Defects Res A Clin Mol Teratol 70:40-46.
55. Lee YH, SG Kim, SH Choi, IS Kim and SH Kim. (2003). Ovarian mature cystic teratoma containing homunculus: a case report. J Korean Med Sci 18:905-907.
56. Usta IM, GA Birjawi and AH Nassar. (2006). Benign cystic teratoma mimicking an abdominal pregnancy. Acta Obstet Gynecol Scand 85:1397-1398.
57. Weiss JR, JR Burgess and KJ Kaplan. (2006). Fetiform teratoma (homunculus). Arch Pathol Lab Med 130:1552-1556.
58. Landry DW and HA Zucker. (2004). Embryonic death and the creation of human embryonic stem cells. J Clin Invest 114:1184-1186.
59. Landry DW, HA Zucker, MV Sauer, M Reznik and L Wiebe. (2006). Hypocellularity and absence of compaction as criteria for embryonic death. Regen Med 1:367-371.
60. Zhang X, P Stojkovic, S Przyborski, M Cooke, L Armstrong, M Lako and M Stojkovic. (2006). Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24:2669-2676.
61. Condic M and E Furton. (2007). Harvesting embryonic stem cells from deceased human embryos. Natl Cathol Bioeth Q 7:507-525.
62. Chung Y, I Klimanskaya, S Becker, J Marh, SJ Lu, J Johnson, L Meisner and R Lanza. (2006). Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439:216-219.
63. Klimanskaya I, Y Chung, S Becker, SJ Lu and R Lanza. (2006). Human embryonic stem cell lines derived from single blastomeres. Nature 444:481-485.
64. Chung Y, I Klimanskaya, S Becker, T Li, M Maserati, S-J Lu, T Zdravkovic, D Ilic, O Genbacev, S Fisher, A Krtolica and R Lanza. (2008). Human Embryonic Stem Cell Lines Generated without Embryo Destruction. Cell Stem Cell, Epub ahead of print, DOI:10.1016/j.stem. 2007.12.013
65. Sermon KD, A Michiels, G Harton, C Moutou, S Repping, PN Scriven, S SenGupta, J Traeger-Synodinos, K Vesela, S Viville, L Wilton and JC Harper. (2007). ESHRE PGD Consortium data collection VI: cycles from January to December 2003 with pregnancy follow-up to October 2004. Hum Reprod 22:323-336.
66. Mastenbroek S, M Twisk, J van Echten-Arends, B Sikkema-Raddatz, JC Korevaar, HR Verhoeve, NE Vogel, EG Arts, JW de Vries, PM Bossuyt, CH Buys, MJ Heineman, S Repping and F van der Veen. (2007). In vitro fertilization with preimplantation genetic screening. N Engl J Med 357:9-17.
67. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA Largaespada and CM Verfaillie. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
68. De Coppi P, G Bartsch, Jr., MM Siddiqui, T Xu, CC Santos, L Perin, G Mostoslavsky, AC Serre, EY Snyder, JJ Yoo, ME Furth, S Soker and A Atala. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnol 25:100-106.
69. Strelchenko N, O Verlinsky, V Kukharenko and Y Verlinsky. (2004). Morula-derived human embryonic stem cells. Reprod Biomed Online 9:623-629.
70. Brons IG, LE Smithers, MW Trotter, P Rugg-Gunn, B Sun, SM Chuva de Sousa Lopes, SK Howlett, A Clarkson, L Ahrlund-Richter, RA Pedersen and L Vallier. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448:191-195.
71. Tesar PJ, JG Chenoweth, FA Brook, TJ Davies, EP Evans, DL Mack, RL Gardner and RD McKay. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196-199.